Natural Alternatives International (NASDAQ:NAII) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a research report released on Friday. The firm issued a buy rating on the stock.

Natural Alternatives International Price Performance

NAII stock opened at $4.24 on Friday. The company has a quick ratio of 1.50, a current ratio of 2.56 and a debt-to-equity ratio of 0.11. The firm has a market cap of $26.28 million, a price-to-earnings ratio of -2.94 and a beta of 0.60. The company’s fifty day simple moving average is $4.44 and its 200 day simple moving average is $5.37. Natural Alternatives International has a 12-month low of $4.02 and a 12-month high of $7.26.

Natural Alternatives International (NASDAQ:NAII) last announced its quarterly earnings data on Friday, September 27th. The company reported ($0.32) earnings per share (EPS) for the quarter. Natural Alternatives International had a negative net margin of 7.53% and a negative return on equity of 10.23%. The business had revenue of $29.49 million during the quarter.

Institutional Investors Weigh In On Natural Alternatives International

An institutional investor recently raised its position in Natural Alternatives International stock. Geode Capital Management LLC lifted its holdings in shares of Natural Alternatives International, Inc. (NASDAQ:NAII) by 6.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 45,062 shares of the company’s stock after acquiring an additional 2,915 shares during the period. Geode Capital Management LLC owned approximately 0.73% of Natural Alternatives International worth $258,000 at the end of the most recent reporting period. Institutional investors own 32.40% of the company’s stock.

About Natural Alternatives International

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.